Jazz Pharmaceuticals plc (JAZZ) insider trading
Every open-market stock purchase and sale by Jazz Pharmaceuticals plc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Robert Iannone (C-suite exec) and 3 others sold $24.4M in the last 90 days.
- Last insider buy: Seamus Mulligan (Director), $167K, 17 months ago.
Last 12 months: insiders bought $0 (0 buys) and sold $68.5M (30 sales). Last close $245.80 on Sep 11, 2026.
Recent JAZZ insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Sep 10, 2026 | Neena M Patil (C-suite exec) | Sold | $289K |
| Sep 8, 2026 | Renee D Gala (CEO) | Sold | $486K |
| Sep 8, 2026 | Renee D Gala (CEO) | Sold (not open market) | $485K |
| Sep 8, 2026 | Mary Elizabeth Henderson (VP) | Sold (not open market) | $343K |
| Sep 8, 2026 | Mary Elizabeth Henderson (VP) | Sold (not open market) | $3.6K |
| Sep 1, 2026 | Bruce C Cozadd (Director) | Sold | $1.5M |
| Aug 31, 2026 | Mary Elizabeth Henderson (VP) | Sold (not open market) | $501K |
| Aug 31, 2026 | Patrick Kennedy (Director) | Sold (not open market) | $444K |
| Aug 31, 2026 | Heather Ann McSharry (Director) | Sold (not open market) | $444K |
| Aug 31, 2026 | Jennifer E. Cook (Director) | Sold (not open market) | $408K |
| Aug 31, 2026 | Norbert G Riedel (Director) | Sold (not open market) | $408K |
| Aug 31, 2026 | Rick E Winningham (Director) | Sold (not open market) | $408K |
| Aug 31, 2026 | Mark Douglas Smith (Director) | Sold (not open market) | $408K |
| Aug 31, 2026 | Laura Hamill (Director) | Sold (not open market) | $408K |
| Aug 31, 2026 | Patrick G Enright (Director) | Sold (not open market) | $408K |
| Aug 31, 2026 | Bruce C Cozadd (Director) | Sold (not open market) | $292K |
| Aug 31, 2026 | Ted W Love (Director) | Sold (not open market) | $178K |
| Aug 31, 2026 | Mary Elizabeth Henderson (VP) | Sold (not open market) | $3.9K |
| Aug 31, 2026 | Heather Ann McSharry (Director) | Sold (not open market) | $3.7K |
| Aug 31, 2026 | Patrick Kennedy (Director) | Sold (not open market) | $3.7K |
| Aug 31, 2026 | Norbert G Riedel (Director) | Sold (not open market) | $3.4K |
| Aug 31, 2026 | Mark Douglas Smith (Director) | Sold (not open market) | $3.4K |
| Aug 31, 2026 | Patrick G Enright (Director) | Sold (not open market) | $3.4K |
| Aug 31, 2026 | Rick E Winningham (Director) | Sold (not open market) | $3.4K |
| Aug 31, 2026 | Laura Hamill (Director) | Sold (not open market) | $3.4K |
Who's trading JAZZ
- Neena M Patil, C-suite exec: sold $11.5M (14 sales), last Sep 10, 2026
- Renee D Gala, COO: sold $486K (1 sale), last Sep 8, 2026
- Mary Elizabeth Henderson, VP: sold $1.4M (2 sales), last Sep 8, 2026
- Bruce C Cozadd, Director: sold $26.9M (20 sales), last Sep 1, 2026
- Rick E Winningham, Director: sold $1.7M (2 sales), last Aug 31, 2026
- Jennifer E. Cook, Director: other filings, last Aug 31, 2026
- Patrick G Enright, Director: other filings, last Aug 31, 2026
- Laura Hamill, Director: other filings, last Aug 31, 2026
- Patrick Kennedy, Director: other filings, last Aug 31, 2026
- Ted W Love, Director: other filings, last Aug 31, 2026
- Heather Ann McSharry, Director: sold $1.1M (2 sales), last Aug 31, 2026
- Norbert G Riedel, Director: sold $656K (1 sale), last Aug 31, 2026
- Mark Douglas Smith, Director: sold $267K (1 sale), last Aug 31, 2026
- Robert Iannone, C-suite exec: sold $20.4M (7 sales), last Aug 27, 2026
- Samantha Pearce, C-suite exec: sold $1.6M (1 sale), last Aug 5, 2026
Get free alerts when an insider at Jazz Pharmaceuticals plc files a new trade →